New Therapeutical Perspectives in Cases of Phonological Disorders

November 27, 2019 updated by: Marcia Keske Soares, Universidade Federal de Santa Maria
The aim of this study is to verify phonological and auditory aspects of children submitted to traditional phonological therapy, phonological therapy using a software and placebo therapy in children with phonological disorders.

Study Overview

Detailed Description

The study will provide different therapeutic approaches for cases of phonological disorders, the classical approach would be mediated by Cycles Model, innovated approach is performed by means of an intervention speech software-SIFALA, there will still be the group that does not receive any of the proposals therapies that will be the placebo group.The study will provide 25 sessions for each group, with 30 minutes in each group. At the end of these sessions, the placebo group will receive one of the therapeutic approaches. With these three study groups, the investigators understand in what manner to obtain correct sounds is more effective.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Santa Maria, Rio Grande Do Sul, Brazil, 97015-372
        • Universidade Federal de Santa Maria- campus Camobi e centro- Floriano Peixoto 1709.
      • Santa Maria, Rio Grande Do Sul, Brazil, 97060-500
        • Federal University of Santa Maria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 9 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Parents/guardians and child agree to participate and have signed the Informed Consent Form;
  • Have age between 4:0 to 8:11 (years:months);
  • Present diagnosis of phonological disorders;
  • Present hearing thresholds within the normal range

Exclusion Criteria:

  • Present neurological impairment, emotional and/or cognitive clearly diagnosed, or have complaint;
  • Present any degree of hearing loss is the type conductive, mixed or sensorineural, and middle ear disorders in time of selection, as well as having presented otitis complaints;
  • Present language impairment associated with speech sound disorder;
  • Present commitment in the stomatognathic system that can interfere in the speech production;
  • Have been received speech and language therapy before.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional Phonological Therapy
This intervention will be intermediated by the traditional model cycles. This approach has the principle of treating the suppression of operant phonological processes in child's speech, from the awareness of sound-target characteristics operating in that phonological process.
Phonological therapy based on generalizing the sounds presented by figures, repetition and naming words.
Experimental: Software Phonological Therapy- SIFALA
This intervention will be intermediated by the software SIFALA. The software SIFALA, allows to select target segments using the Modelo de Estratos (second model Strata), based on the level segment of production and complexity of distinctive features, from the child's sound system analysis and planned generalizations. It also seeks the treatment of phonological disorders, by selection stimulus words in more favorable environments and playful activities with computer resource for the correct production of the target segment in the words stimulus, promoting the spread segments.
The phonological thearapy of this group will be based on software use with phonological model already developed, using naming and repetition of sounds.
Placebo Comparator: Placebo Therapy
No interventional group. This group will be the sham group. The proposed activities will be fun games on the computer, there is no relationship with speech and it will be not emphasized the correct sound production, will only play activities.
No intervention to improve speech.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument
Time Frame: 10 weeks
The percentage of correct consonants corresponds to the number of phonemes produced by the child, evaluated initially before starting treatment and at the end of treatment. The variable of this calculation is based on the percentage which is determined at what phonological level of disorder the child is at. It is expected that at the end of treatment the percentage of correct consonants will increase due to the therapy stimuli offered.
10 weeks
P300- Long-latency Auditory Evoked Potential
Time Frame: 10 weeks.

Electrophysiological evaluation of the auditory pathway through the protocol, Pretreatment and Post-treatment P300 waves were analyzed by the latency according to the parameters of MacPherson (1996).

The electrophysiological protocol was performed before and after therapy. The marking of the waves was judged by specialist judges in the field of audiology.

The variable that predicts P300 latency is quantified in milliseconds (ms

10 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Marcia Keske-Soares, PhD, Universidade Federal de Santa Maria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2016

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

September 15, 2016

First Submitted That Met QC Criteria

October 12, 2016

First Posted (Estimate)

October 17, 2016

Study Record Updates

Last Update Posted (Actual)

December 18, 2019

Last Update Submitted That Met QC Criteria

November 27, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The plan to make the individual data available is in accordance with the criteria adopted in the research and the research ethics committee of the educational institution, which developed the study.

The results, placed on the platform of this randomized clinical trial, can be used by other researchers.

IPD Sharing Time Frame

Results were exposed for three years

IPD Sharing Access Criteria

Researchers with access to Clinical Trials and those who wish to contact the responsible researcher.

IPD Sharing Supporting Information Type

  • ICF

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe